Ascendis Pharma Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	363.64	266.72	51.17	7.78	6.95	Upgrade
Revenue Growth (YoY)	36.34%	421.20%	557.93%	11.87%	-48.02%	Upgrade
Cost of Revenue	44.26	44.4	12.14	3.52	-	Upgrade
Gross Profit	319.38	222.32	39.04	4.26	6.95	Upgrade
Selling, General & Admin	291.14	264.41	221.23	160.18	76.67	Upgrade
Research & Development	307	413.45	379.62	295.87	260.9	Upgrade
Operating Expenses	598.15	677.86	600.85	456.05	337.57	Upgrade
Operating Income	-278.76	-455.54	-561.81	-451.79	-330.62	Upgrade
Interest Expense	-65.5	-44.07	-30.68	-3.91	-1.92	Upgrade
Interest & Investment Income	14.36	16.86	7.43	0.69	1.81	Upgrade
Earnings From Equity Investments	-20.06	-18.4	-17.7	12.04	-9.52	Upgrade
Currency Exchange Gain (Loss)	-27.15	12.35	40.43	59.03	-78.92	Upgrade
Other Non Operating Income (Expenses)	3.87	14.65	-15.48	-	-	Upgrade
Pretax Income	-373.24	-474.14	-577.82	-383.94	-419.17	Upgrade
Income Tax Expense	4.84	7.3	5.38	-0.37	-0.22	Upgrade
Net Income	-378.08	-481.45	-583.19	-383.58	-418.96	Upgrade
Net Income to Common	-378.08	-481.45	-583.19	-383.58	-418.96	Upgrade
Shares Outstanding (Basic)	58	56	56	55	51	Upgrade
Shares Outstanding (Diluted)	58	56	56	55	51	Upgrade
Shares Change (YoY)	2.85%	0.38%	2.37%	8.21%	8.84%	Upgrade
EPS (Basic)	-6.53	-8.55	-10.40	-7.00	-8.28	Upgrade
EPS (Diluted)	-6.53	-8.55	-10.40	-7.00	-8.28	Upgrade
Free Cash Flow	-307.62	-469.8	-510.19	-441.35	-291.41	Upgrade
Free Cash Flow Per Share	-5.31	-8.35	-9.10	-8.06	-5.76	Upgrade
Gross Margin	87.83%	83.36%	76.28%	54.71%	100.00%	Upgrade
Operating Margin	-76.66%	-170.80%	-1097.85%	-5808.59%	-4755.07%	Upgrade
Profit Margin	-103.97%	-180.51%	-1139.63%	-4931.56%	-6025.53%	Upgrade
Free Cash Flow Margin	-84.60%	-176.14%	-996.97%	-5674.38%	-4191.11%	Upgrade
EBITDA	-273.83	-448.99	-544.3	-436.85	-321.17	Upgrade
EBITDA Margin	-75.30%	-168.34%	-	-	-	Upgrade
D&A For EBITDA	4.94	6.55	17.51	14.95	9.45	Upgrade
EBIT	-278.76	-455.54	-561.81	-451.79	-330.62	Upgrade
EBIT Margin	-76.66%	-170.80%	-	-	-	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q